Page last updated: 2024-08-26

imipenem, anhydrous and E coli Infections

imipenem, anhydrous has been researched along with E coli Infections in 115 studies

Research

Studies (115)

Timeframe	Studies, this research(%)	All Research%
pre-1990	8 (6.96)	18.7374
1990's	21 (18.26)	18.2507
2000's	32 (27.83)	29.6817
2010's	43 (37.39)	24.3611
2020's	11 (9.57)	2.80

Authors

Authors	Studies
Barth, AL; Castanheira, M; Gales, AC; Nicoletti, AG; Pereira, AS; Pignatari, AC	1
Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N	1
Afkou, Z; Ikonomidis, A; Labrou, M; Maniatis, AN; Pournaras, S; Sofianou, D; Tsakris, A	1
Bae, IK; Jeong, SH; Lee, SH; Lee, WG; Lee, YN	1
Arakawa, Y; Suzuki, S; Wachino, J; Yamane, K	1
Apisarnthanarak, A; Kiratisin, P; Laesripa, C; Saifon, P	1
Cauda, R; D'Inzeo, T; De Pascale, G; Fadda, G; Fiori, B; Leone, F; Rossi, M; Sali, M; Sanguinetti, M; Spanu, T; Trecarichi, EM; Tumbarello, M	1
Jarlier, V; Mayer, C; Petrella, S; Renard, M; Sougakoff, W; Ziental-Gelus, N	1
Cattoir, V; Nordmann, P; Poirel, L	1
Carter, PE; Heffernan, HM; Pope, CE	1
Carmeli, Y; Chmelnitsky, I; Goren, MG; Navon-Venezia, S	1
Badal, RE; Baquero, F; Bouchillon, SK; Cantón, R; Hawser, SP; Hoban, DJ	1
Cars, O; Löwdin, E; Melhus, A; Tängdén, T	1
Blumstein, AC; Diethelm, S; Enderlin-Paput, M; Gauvin, JC; Gnerre, C; Herrmann, C; Jacob, L; Lange, R; Locher, HH; Masse, F; Mathieu, G; Mirre, A; Panchaud, P; Ritz, D; Rueedi, G; Schmitt, C; Seeland, S; Seiler, P; Surivet, JP	1
Haider Naqvi, SZ; Malik, A; Muddassir, M; Mumtaz, K; Munir, S; Raza, A; Shoaib Ahmed, S; Waqas, K	1
Ahmed, S; Ali, F; Andleeb, F; Gul, S; Rasheed, A; Sabir, MS; Sardar, S; Shakeela, Q; Ullah, A	1
Al Atbee, MYN; Jalil, MB	1
Akeda, Y; Hamada, S; Iida, T; Matsumoto, Y; Motooka, D; Sakamoto, N; Sugawara, Y	1
Abulreesh, HH; Ahmad, I; Aldosari, MS; Alshehri, WA; Arafa, SH; Asiri, FH; Elbanna, K; Obaid, NA; Organji, SR	1
Antonelli, A; Camarlinghi, G; Coppi, M; Giani, T; Mattei, R; Nardone, M; Parisio, EM; Riccobono, E; Rossolini, GM	1
Fu, L; Li, H; Li, X; Liu, J; Luo, S; Wan, Z; Wang, Y; Wu, X; Xie, X; Zhao, Z	1
Ebede, SO; Nwafia, IN; Ohanu, ME; Ozumba, UC	1
Anacker, M; Castanheira, M; Johnson, JR; Johnston, BD; Porter, SB; Thuras, P; Vagnone, PS; VonBank, B; Witwer, M	1
Canovas, J; Chau, F; Fantin, B; Le Monnier, A; Lefort, A; Petitjean, G	1
Hirabayashi, A; Kajihara, T; Shibayama, K; Sugai, M; Yahara, K	1
Clabots, C; Johnson, JR; Johnston, BD; Porter, SB; Thuras, P	1
Debarbieux, L; Delattre, R; Dufour, N; Ricard, JD	1
Ali, I; Shabbir, M	1
Badal, R; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S	1
Abdelwahab, SI; Dafalla, OME; Homeida, HE; Taha, MME	1
Bhattacharjee, A; Deshamukhya, C; Gajamer, VR; Paul, D; Pradhan, N; Singh, AK; Tiwari, HK	1
Docobo-Pérez, F; Domínguez-Herrera, J; Egea, P; López-Cerero, L; López-Rojas, R; Pachón, J; Pascual, A; Rodríguez-Baño, J	1
Chae, JY; Kim, JW; Moon, du G; Oh, MM; Park, MG; Yoon, CY	1
Biçmen, M; Gülay, Z; Sarı, AN	1
Belghiti, J; Bert, F; Dondero, F; Durand, F; Larroque, B; Moreau, R; Nicolas-Chanoine, MH; Paugam-Burtz, C	1
Hidalgo, G; Hidalgo, M; Jugo, MB; Maccallini, GC; Villar, HE; Visser, M	1
Camera, M; Coppo, E; Del Bono, V; Marchese, A; Orengo, G; Ventura, F; Viscoli, C	1
Fernández, J; Fleites, A; Montero, I; Rodicio, MR	1
Chau, F; Couffignal, C; Fantin, B; Lepeule, R; Massias, L; Mentre, F; Rossi, B; Ruppé, E; Soubirou, JF	1
Cuesta-Bernal, J; El-Delik, J; Frank, D; Göttig, S; Klingler, FM; Koenigs, A; Müller, HF; Pogoryelov, D; Pos, KM; Proschak, E; Sjuts, H; Wichelhaus, TA	1
Aissa, N; Bert, F; Labia, R; Lozniewski, A; Mayer, N; Nicolas-Chanoine, MH	1
Chongtrakool, P; Diraphat, P; Malathum, K; Pornsinchai, P; Siripanichgon, K	1
Aksaray, S; Avcıküçük, H; Başustaoğlu, A; Kaşkatepe, B; Süzük, S	1
Hung, YP; Ko, WC; Lee, JC; Li, CW; Li, MC; Lin, HJ; Liu, HC; Wu, YH	1
Ak, S; Ay Altıntop, Y; Balcı, PÖ; Budak, EE; Çalışkan, A; Çizmeci, Z; Çopur Çiçek, A; Fırat, M; Özgümüş, OB; Sancaktar, M; Sandallı, C; Sarı, F; Şay Coşkun, SU; Yağmur, G; Yıldız, N	1
Ahmad, I; Akhtar, T; Ambreen, A; Gandapor, AJ; Khan, A; Khan, AM; Ullah, O	1
Chen, ZL; Liu, SW; Wu, WK; Xu, J; Xu, XY; Yuan, JY; Zhang, N	1
Boyanova, L; Kaneva, R; Markovska, R; Mitev, V; Mitov, I; Pencheva, D; Stankova, P; Stoeva, T	1
Ajao, AO; Albrecht, JS; Furuno, JP; Harris, AD; Johnson, JK; Pineles, LL; Robinson, GL; Thom, KA; Zhao, L	1
Fish, DE; Gluzman, A; Middleton, K	1
Bautista, V; Campos, J; Delgado-Iribarren, A; García-Cobos, S; Martínez-Martínez, L; Oteo, J; Pérez-Vázquez, M; Rodríguez, MC; Saavedra, JM; Vega, D; Velasco, M	1
Choe, KW; Jeon, JH; Kim, HB; Kim, NJ; Lee, HS; Oh, MD; Park, SW; Park, WB; Song, KH	1
Ahmadi, S; Bazzaz, BS; Farshadzadeh, Z; Mohamadpoor, AH; Naderinasab, M; Yousefi, F	1
Lim, KT; Puthucheary, S; Thong, KL; Yasin, R; Yeo, CC	1
Lee, CH; Lin, WC; Liu, JW; Su, LH; Tang, YF	1
Du, X; Jiang, X; Li, G; Wang, Y; Wei, Q; Zhao, Y	1
Kochhar, R; Noor, MT; Radhakrishna, Y; Ray, P; Singh, K; Sinha, SK; Wig, JD	1
Armero, C; Gobernado, M; González, F; López-Quílez, A; Perpiñán, H; Sahuquillo-Arce, JM; Selva, M; Vanaclocha, H	1
Ersoy, Y; Görgeç, S; Kuzucu, C; Yetkin, F	1
Hsueh, PR; Huang, WH; Ko, WC; Lee, NY; Tsui, KC	1
Badal, RE; Bouchillon, SK; Cantón, R; Hackel, M; Hawser, SP; Hoban, DJ; Lascols, C	1
Basu, S; Nandy, RK; Roy, S; Singh, AK; Viswanathan, R	1
Chau, F; Fantin, B; Le, P; Lefort, A; Lepeule, R; Massias, L; Nucci, A; Ruppé, E	1
Hsueh, PR; Huang, WH; Ko, WC; Lee, CC; Lee, NY; Tsui, KC	1
Anderson, DJ; Bennett, KM; Dotson, TL; Sarraf-Yazdi, S; Sharpe, M; Vaslef, SN	1
Bansal, N; Chander, J; Gupta, V; Singla, N	1
Fallah, F; Goudarzi, M; Jahromi, MH; Karimi, A; Navidinia, M; Sajadi Nia, RS; Shiva, F	1
Duttaroy, DD; González Patzán, LD; Kreidly, Z; Lipka, J; Sable, C; Stricklin, D; Vazquez, JA	1
Harada, S; Ishii, Y; Kimura, S; Livermore, DM; Saga, T; Tateda, K; Woodford, N; Yamaguchi, K; Yoshizumi, A	1
El-Sukhon, SN; Faiza Boukhatem, Z	1
Ackermann, G; Beer, J; Blatz, R; Rodloff, AC; Schaumann, R	1
Cirioni, O; D'Amato, G; Ghiselli, R; Giacometti, A; Mocchegiani, F; Orlando, F; Saba, V; Scalise, G; Sisti, V	1
Héritier, C; Nordmann, P; Poirel, L; Spicq, C	1
Cirioni, O; D'Amato, G; Ghiselli, R; Giacometti, A; Kamysz, W; Mocchegiani, F; Orlando, F; Rocchi, M; Saba, V; Scalise, G; Silvestri, C; Łukasiak, J	1
Benbachir, M; Benchekroun, S; Harif, M; Loukili, A; Mahmal, L; Quessar, A	1
Abdalhamid, B; Fabian, D; Farajallah, A; Hanson, ND; Hong, T; Levine, J; Moland, ES; Sloan, C; Thomson, KS; Wang, J	1
Arlet, G; Bidet, P; Bingen, E; Brahimi, N; Burghoffer, B; El-Ghoneimi, A; Gautier, V; Mariani-Kurkdjian, P	1
Bergnach, C; Cirioni, O; Ghiselli, R; Giacometti, A; Licci, A; Mocchegiani, F; Orlando, F; Rocchi, M; Saba, V; Scalise, G; Silvestri, C; Skerlavaj, B; Zanetti, M	1
Choi, SJ; Lee, JH	1
Antón-Aranda, E; Martí Cabané, J	1
Lartigue, MF; Nordmann, P; Poirel, L; Poyart, C; Réglier-Poupet, H	1
Carrero, HA; Erwin, DP; Ewell, AJ; Mody, RM; Moran, KA; Selby, EB; Summers, AM	1
Melzer, M; Petersen, I	1
McCracken, GH; Patamasucon, P	1
Bucklin, SE; Lake, P; Lögdberg, L; Morrison, DC	1
Akamo, Y; Manabe, T; Mizokami, M; Mizuno, I; Mohri, N; Shinagawa, N; Takeyama, H; Yuasa, H	1
Bucklin, SE; Morrison, DC	2
Isbister, WH; Sanea, O	1
Bucklin, SE; Fujihara, Y; Leeson, MC; Morrison, DC	1
Andremont, A; Carbon, C; Massias, L; Montravers, P	1
Brook, I; Ledney, GD	1
Casewell, M; Fagan, E; Gimson, A; Philpott-Howard, J; Rolando, N; Sahathevan, M; Westaby, D; Williams, R	1
Dalhoff, A; Nitsche, D; Oesser, S; Sack, M; Schulze, C	1
Ariga, K; Shinagawa, N; Suzuki, K; Yamakoshi, M; Yamamoto, T	1
Hiramatsu, K; Tateda, E; Yokota, T; Yoshida, T	1
Goto, S; Matsunaga, T; Nagashima, M; Ogawa, M; Shimohira, H; Yoshida, T	1
Bradford, PA; Bush, K; Mariano, N; Projan, SJ; Rahal, JJ; Urban, C	1
Hatakeyama, N; Horiguchi, A; Ikeuchi, K; Oyama, M	1
Xiao, Z	1
Abe, K; Oishi, Y; Ueda, M; Wada, T	1
Cirioni, O; Ghiselli, R; Giacometti, A; Mocchegiani, F; Orlando, F; Pacci, AM; Saba, V; Scalise, G	1
Bonomo, RA; Hujer, AM; Kelkar, S; Odeh, R; Quinn, JP; Schreckenberger, PC	1
Atkinson, AM; Teale, DM	1
Kletchko, S; Nagappan, R	1
Hopkins, JA; Lami, JL; Wilson, SE	1
Guiot, HF; Mattie, H; van Furth, R; van Ogtrop, ML	1
Isert, D; Klesel, N; Limbert, M; Markus, A; Schrinner, E; Seibert, G	1
Dworkin, RJ; Kennedy, SL; Sachdeva, M; Sande, MA; Tureen, JH	1
Baron, S; Bégué, P; Challier, P; Fontaine, JL; Lasfargues, G; Quinet, B	1
Brook, I	1
Hashizume, T; Kemi, M; Komatsu, T; Ogashiwa, M; Okumoto, Y; Takase, Z	1
Satoh, K; Watanabe, A	1
Alpert, G; Bloh, AM; Campos, JM; Connor, E; Dagan, R; Plotkin, SA; Powell, KR	1
Kim, KS	1

Reviews

1 review(s) available for imipenem, anhydrous and E coli Infections

Article	Year
[A case of psoas abscess associated in the elderly]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1996, Volume: 70, Issue:4 Topics: Aged; Aged, 80 and over; Cilastatin; Diabetes Complications; Drainage; Drug Therapy, Combination; Escherichia coli Infections; Humans; Imipenem; Male; Proteus Infections; Proteus mirabilis; Psoas Abscess; Sepsis	1996

Trials

3 trial(s) available for imipenem, anhydrous and E coli Infections

Article	Year
Efficacy and safety of ceftazidime-avibactam versus imipenem-cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study. Current medical research and opinion, 2012, Volume: 28, Issue:12 Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Cilastatin; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Male; Middle Aged; Prospective Studies; Protease Inhibitors; Pyelonephritis; Urinary Tract Infections	2012
Infectious sequelae after endoscopic sclerotherapy of oesophageal varices: role of antibiotic prophylaxis. Journal of hepatology, 1993, Volume: 18, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli Infections; Esophageal and Gastric Varices; Esophageal Diseases; Esophagoscopy; Female; Humans; Imipenem; Male; Middle Aged; Prospective Studies; Sclerotherapy; Staphylococcal Infections; Staphylococcus aureus	1993
Adjunctive antimicrobials in surgery of soft tissue infections: evaluation of cephalosporins and carbapenems. The American surgeon, 1991, Volume: 57, Issue:12 Topics: Adult; Aged; Bacterial Infections; Carbapenems; Cefmetazole; Cefoperazone; Cefotetan; Cefoxitin; Cephalosporins; Drug Combinations; Drug Resistance, Microbial; Escherichia coli Infections; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Prospective Studies; Remission Induction; Skin Diseases, Infectious; Staphylococcal Infections; Streptococcal Infections; Thienamycins	1991

Other Studies

111 other study(ies) available for imipenem, anhydrous and E coli Infections

Article	Year
First report of plasmid-mediated qnrA1 in a ciprofloxacin-resistant Escherichia coli strain in Latin America. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4 Topics: Anti-Bacterial Agents; Ciprofloxacin; Conjugation, Genetic; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Integrons; Latin America; Molecular Sequence Data; Plasmids	2007
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6 Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal	2007
First occurrence of an Escherichia coli clinical isolate producing the VIM-1/VIM-2 hybrid metallo-beta-lactamase VIM-12. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:8 Topics: Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Conjugation, Genetic; Escherichia coli; Escherichia coli Infections; Humans; Male; Microbial Sensitivity Tests; Plasmids; Recombination, Genetic	2007
Novel complex class 1 integron bearing an ISCR1 element in an Escherichia coli isolate carrying the blaCTX-M-14 gene. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:8 Topics: Adult; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; DNA Transposable Elements; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Integrons; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Pneumonia, Bacterial; Sequence Analysis, DNA	2007
Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4 Topics: Anti-Bacterial Agents; Conjugation, Genetic; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fluoroquinolones; Hospitals; Humans; Japan; Microbial Sensitivity Tests; Plasmids; Prevalence	2008
Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8 Topics: Adult; Bacterial Proteins; beta-Lactamases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Endemic Diseases; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Polymerase Chain Reaction; Sequence Analysis, DNA; Thailand	2008
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Risk Factors; Treatment Failure	2008
Genetic and structural insights into the dissemination potential of the extremely broad-spectrum class A beta-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same patient in France. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10 Topics: Aged; Base Sequence; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Catalytic Domain; Cephalosporin Resistance; Crystallography, X-Ray; DNA Primers; DNA, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; France; Genes, Bacterial; Humans; Imipenem; Kinetics; Male; Models, Molecular; Mutation	2008
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10 Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids	2008
CMY-29 and CMY-30, two novel plasmid-mediated AmpC beta-lactamases. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:7 Topics: Anti-Bacterial Agents; beta-Lactamases; Cefoxitin; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; New Zealand; Plasmids	2009
Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6 Topics: Academic Medical Centers; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; DNA Primers; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Humans; In Vitro Techniques; Israel; Microbial Sensitivity Tests; Molecular Epidemiology; Plasmids; Time Factors	2010
Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Antimicrob Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:7 Topics: Abdomen; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae	2010
Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactamases; Child; Child, Preschool; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Sweden; Travel; White People; Young Adult	2010
Optimization of LpxC Inhibitor Lead Compounds Focusing on Efficacy and Formulation for High Dose Intravenous Administration. Journal of medicinal chemistry, 2020, 01-09, Volume: 63, Issue:1 Topics: Administration, Intravenous; Amidohydrolases; Animals; Anti-Bacterial Agents; Enzyme Inhibitors; Escherichia coli Infections; Gram-Negative Bacteria; Hepatocytes; Hydroxamic Acids; Mice; Microbial Sensitivity Tests; Molecular Structure; Rats; Solubility	2020
Antibiogram and molecular characterization of multi-drug resistant microorganisms isolated from urinary tract infections. Pakistan journal of pharmaceutical sciences, 2021, Volume: 34, Issue:3(Suppleme Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nitrofurantoin; Oxacillin; Pakistan; Pipemidic Acid; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections	2021
Comparative in vitro activity of selected antibacterial agents against Escherichia coli isolated from hospitalized patients suffering UTI. Pakistan journal of pharmaceutical sciences, 2022, Volume: 35, Issue:2 Topics: Anti-Bacterial Agents; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Sulfamethoxazole; Tobramycin; Trimethoprim; Urinary Tract Infections	2022
The prevalence of multiple drug resistance Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infections. Journal of clinical laboratory analysis, 2022, Volume: 36, Issue:9 Topics: Ampicillin; Anti-Bacterial Agents; Aztreonam; Cefepime; Ceftazidime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Piperacillin; Prevalence; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections	2022
Role of Chromosome- and/or Plasmid-Located Microbiology spectrum, 2022, 08-31, Volume: 10, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Chromosomes; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Microbial Sensitivity Tests; Plasmids	2022
Antimicrobial Resistance, Virulence Factor-Encoding Genes, and Biofilm-Forming Ability of Community-Associated Uropathogenic Polish journal of microbiology, 2022, Sep-01, Volume: 71, Issue:3 Topics: Agar; Ampicillin; Animals; Anti-Bacterial Agents; Biofilms; Drug Resistance, Bacterial; Ertapenem; Escherichia coli Infections; Female; Imipenem; Meropenem; Norfloxacin; Saudi Arabia; Sheep; Urinary Tract Infections; Uropathogenic Escherichia coli; Virulence Factors	2022
Variable performance of different commercial systems for testing carbapenem susceptibility of KPC carbapenemase-producing Escherichia coli. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2019, Volume: 25, Issue:11 Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Diagnostic Errors; Ertapenem; Escherichia coli; Escherichia coli Infections; Genotype; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Molecular Typing; Random Amplified Polymorphic DNA Technique	2019
In vitro and in vivo assessment of the antibacterial activity of colistin alone and in combination with other antibiotics against Acinetobacter baumannii and Escherichia coli. Journal of global antimicrobial resistance, 2020, Volume: 20 Topics: Acinetobacter baumannii; Administration, Intravenous; Animals; Anti-Bacterial Agents; Biofilms; Colistin; Disease Models, Animal; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; Monte Carlo Method; Sulbactam; Treatment Outcome; Urinary Tract Infections	2020
Molecular detection and antibiotic resistance pattern of extended-spectrum beta-lactamase producing Escherichia coli in a Tertiary Hospital in Enugu, Nigeria. Annals of clinical microbiology and antimicrobials, 2019, Dec-12, Volume: 18, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Genes, Bacterial; Humans; Imipenem; Male; Middle Aged; Nigeria; Risk Factors; Tertiary Care Centers; Young Adult	2019
Activity of Imipenem-Relebactam against Carbapenem-Resistant Escherichia coli Isolates from the United States in Relation to Clonal Background, Resistance Genes, Coresistance, and Region. Antimicrobial agents and chemotherapy, 2020, 04-21, Volume: 64, Issue:5 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Genotype; Geography; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; United States	2020
Expression of CTX-M-15 limits the efficacy of ceftolozane/tazobactam against Escherichia coli in a high-inoculum murine peritonitis model. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2020, Volume: 26, Issue:10 Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Cephalosporins; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Imipenem; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Peritonitis; Tazobactam	2020
Geographical distribution of Enterobacterales with a carbapenemase IMP-6 phenotype and its association with antimicrobial use: An analysis using comprehensive national surveillance data on antimicrobial resistance. PloS one, 2020, Volume: 15, Issue:12 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Japan; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Phenotype	2020
Comparative activity of plazomicin against extended-spectrum cephalosporin-resistant Escherichia coli clinical isolates (2012-2017) in relation to phylogenetic background, sequence type 131 subclones, bla European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2021, Volume: 40, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Genotype; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Phylogeny; Sisomicin; Young Adult	2021
The Lysis of Pathogenic Escherichia coli by Bacteriophages Releases Less Endotoxin Than by β-Lactams. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, Jun-01, Volume: 64, Issue:11 Topics: Anti-Bacterial Agents; beta-Lactams; Cell Survival; Coliphages; Endotoxins; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Phage Therapy; Spheroplasts	2017
Antibiotics susceptibility patterns of uropathogenic E. coli with special reference to fluoroquinolones in different age and gender groups. JPMA. The Journal of the Pakistan Medical Association, 2017, Volume: 67, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Cefoperazone; Child; Child, Preschool; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Imipenem; Infant; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Sulbactam; Tazobactam; Urinary Tract Infections; Young Adult	2017
Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients. BMC infectious diseases, 2017, 12-18, Volume: 17, Issue:1 Topics: Abdomen; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; China; Community-Acquired Infections; Cross Infection; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Incidence; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests	2017
Multidrug resistance, prevalence and phylogenetic analysis of genes encoding class II and III integrons in clinically isolated Escherichia coli. Cellular and molecular biology (Noisy-le-Grand, France), 2018, Apr-30, Volume: 64, Issue:5 Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Base Sequence; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Expression Regulation, Bacterial; Gentamicins; Hospitals; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Nalidixic Acid; Ofloxacin; Phylogeny; Polymerase Chain Reaction; Prevalence; Saudi Arabia; Sequence Alignment	2018
Escherichia coli encoding bla Journal of global antimicrobial resistance, 2018, Volume: 14 Topics: Adult; beta-Lactamases; Community-Acquired Infections; Ertapenem; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Imipenem; India; Meropenem; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Plasmids; Urinary Tract Infections; Young Adult	2018
Inoculum effect on the efficacies of amoxicillin-clavulanate, piperacillin-tazobactam, and imipenem against extended-spectrum β-lactamase (ESBL)-producing and non-ESBL-producing Escherichia coli in an experimental murine sepsis model. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:5 Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; beta-Lactamases; Colony Count, Microbial; Escherichia coli; Escherichia coli Infections; Female; Imipenem; Injections, Intramuscular; Injections, Intraperitoneal; Intraabdominal Infections; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Treatment Outcome	2013
Positive culture for extended-spectrum β-lactamase during acute prostatitis after prostate biopsy is a risk factor for progression to chronic prostatitis. Urology, 2013, Volume: 81, Issue:6 Topics: Aged; Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Blood; Cefoxitin; Disease Progression; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Image-Guided Biopsy; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Prostate; Prostatitis; Quinolones; Urine	2013
[Investigation of plasmid mediated AmpC beta-lactamases among Escherichia coli and Klebsiella pneumoniae isolated from blood cultures]. Mikrobiyoloji bulteni, 2013, Volume: 47, Issue:4 Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Cefotaxime; Cefoxitin; Ceftazidime; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Plasmids	2013
Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients. Transplant infectious disease : an official journal of the Transplantation Society, 2014, Volume: 16, Issue:1 Topics: Adult; Amikacin; beta-Lactamases; beta-Lactams; Cefoxitin; Ciprofloxacin; Drug Resistance, Bacterial; End Stage Liver Disease; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Feces; Female; Humans; Imipenem; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Preoperative Period; Risk Factors; Severity of Illness Index	2014
[In vitro emergence of ertapenem resistance in Escherichia coli producing extended-spectrum β-lactamase]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2014, Volume: 27, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Imipenem; Meropenem; Microbial Sensitivity Tests; Mutation; Thienamycins	2014
Identification of a New Delhi metallo-β-lactamase-4 (NDM-4)-producing Escherichia coli in Italy. BMC microbiology, 2014, Jun-07, Volume: 14 Topics: Aged; Bacterial Proteins; beta-Lactamases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Genotype; Humans; Imipenem; Italy; Male; Middle Aged; Multilocus Sequence Typing	2014
Cluster of Escherichia coli isolates producing a plasmid-mediated OXA-48 β-lactamase in a Spanish hospital in 2012. Journal of clinical microbiology, 2014, Volume: 52, Issue:9 Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Conjugation, Genetic; Ertapenem; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Gene Transfer, Horizontal; Genotype; Hospitals; Humans; Imipenem; Male; Middle Aged; Plasmids; Spain	2014
Activity of temocillin in a murine model of urinary tract infection due to Escherichia coli producing or not producing the ESBL CTX-M-15. The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:5 Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Female; Imipenem; Mice, Inbred CBA; Microbial Sensitivity Tests; Penicillins; Treatment Outcome; Urinary Tract Infections	2015
Approved Drugs Containing Thiols as Inhibitors of Metallo-β-lactamases: Strategy To Combat Multidrug-Resistant Bacteria. Journal of medicinal chemistry, 2015, Apr-23, Volume: 58, Issue:8 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Crystallography, X-Ray; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Models, Molecular; Pseudomonas aeruginosa; Pseudomonas Infections; Sulfhydryl Compounds	2015
A new mechanism to render clinical isolates of Escherichia coli non-susceptible to imipenem: substitutions in the PBP2 penicillin-binding domain. The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:1 Topics: Amino Acid Substitution; Anti-Bacterial Agents; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Imipenem; Microbial Sensitivity Tests; Mutation, Missense; Penicillin-Binding Proteins; Recombination, Genetic; Reverse Genetics	2016
EMERGENCY ROOM: AN UNRECOGNIZED SOURCE OF EXTENDED-SPECTRUM β-LACTAMASE PRODUCING ESCHERICHIA COLI AND KLEBSIELLA PNEUMONIAE. The Southeast Asian journal of tropical medicine and public health, 2015, Volume: 46, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Emergency Service, Hospital; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Plasmids; Thailand; Thienamycins; Young Adult	2015
[The comparison of antibiotic susceptibilities of uropathogenic Escherichia coli isolates in transition from CLSI to EUCAST]. Mikrobiyoloji bulteni, 2015, Volume: 49, Issue:4 Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteriuria; Cefuroxime; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Escherichia coli Infections; European Union; Gentamicins; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Reference Standards; Sulbactam; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey; Urinary Tract Infections; Uropathogenic Escherichia coli	2015
Antimicrobial susceptibility of clinical Enterobacteriaceae isolates at the emergency department in a regional hospital: A threat of extended spectrum beta-lactamase-producers among nursing home residents. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2016, Volume: 49, Issue:4 Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Blood; Drug Resistance, Multiple, Bacterial; Emergency Service, Hospital; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Nursing Homes; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Proteus Infections; Proteus mirabilis; Retrospective Studies; Sputum; Taiwan; Thienamycins; Urine	2016
[Characterization of class 1 and class 2 integron gene cassettes in Escherichia coli strains isolated from urine cultures: a multicenter study]. Mikrobiyoloji bulteni, 2016, Volume: 50, Issue:2 Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteriuria; Escherichia coli Infections; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sequence Analysis, DNA; Streptomycin; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey; Urinary Tract Infections; Uropathogenic Escherichia coli	2016
Antibiotic Sensitivity pattern of Bacterial Isolates of Neonatal Septicemia in Peshawar, Pakistan. Archives of Iranian medicine, 2016, Volume: 19, Issue:12 Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Enoxacin; Escherichia coli; Escherichia coli Infections; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Infant, Low Birth Weight; Infant, Newborn; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Neonatal Sepsis; Ofloxacin; Pakistan; Proteus; Proteus Infections; Pseudomonas; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis	2016
Multi-drug resistant uropathogenic Escherichia coli and its treatment by Chinese medicine. Chinese journal of integrative medicine, 2017, Volume: 23, Issue:10 Topics: Animals; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drugs, Chinese Herbal; Escherichia coli Infections; Female; Imipenem; Mice, Inbred BALB C; Organ Specificity; Treatment Outcome; Uropathogenic Escherichia coli; Virulence	2017
Isolation of Escherichia coli ST131 producing KPC-2 in Bulgaria. Infectious diseases (London, England), 2017, Volume: 49, Issue:5 Topics: Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Bulgaria; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cefotaxime; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Microbial Sensitivity Tests; Phylogeny; Plasmids	2017
Carbapenem MICs in Escherichia coli and Klebsiella Species Producing Extended-Spectrum β-Lactamases in Critical Care Patients from 2001 to 2009. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:4 Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Critical Care; Doripenem; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Gene Expression; Genotype; Humans; Imipenem; Klebsiella; Klebsiella Infections; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Thienamycins; United States	2017
Atypical presentation of osteomyelitis, discitis, epidural, and iliopsoas abscess in diffuse idiopathic skeletal hyperostosis (DISH) syndrome. American journal of physical medicine & rehabilitation, 2008, Volume: 87, Issue:11 Topics: Aged; Anti-Bacterial Agents; Discitis; Escherichia coli Infections; Humans; Hyperostosis, Diffuse Idiopathic Skeletal; Imipenem; Magnetic Resonance Imaging; Male; Osteomyelitis; Psoas Abscess; Radiography	2008
Emergence of imipenem resistance in clinical Escherichia coli during therapy. International journal of antimicrobial agents, 2008, Volume: 32, Issue:6 Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; Conjugation, Genetic; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Female; Genes, Bacterial; HIV Infections; Humans; Imipenem; Microbial Sensitivity Tests; Middle Aged; Mutation; Surgical Wound Infection; Virulence Factors	2008
Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: a retrospective matched case-control study. BMC infectious diseases, 2009, Apr-12, Volume: 9 Topics: Aged; Anti-Bacterial Agents; Ascites; beta-Lactam Resistance; beta-Lactamases; Case-Control Studies; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella; Klebsiella Infections; Liver Cirrhosis; Male; Middle Aged; Peritonitis; Retrospective Studies; Risk Factors; Treatment Failure	2009
The prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates from a general hospital in Iran. Acta microbiologica et immunologica Hungarica, 2009, Volume: 56, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactamases; Escherichia coli; Escherichia coli Infections; Female; Hospitals, General; Humans; Imipenem; Iran; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Prevalence	2009
Characterization of multidrug resistant ESBL-producing Escherichia coli isolates from hospitals in Malaysia. Journal of biomedicine & biotechnology, 2009, Volume: 2009 Topics: Anti-Bacterial Agents; beta-Lactamases; Cluster Analysis; DNA Fingerprinting; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Genotype; Humans; Imipenem; Integrases; Integrons; Malaysia; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Retrospective Studies	2009
Refractory vertebral osteomyelitis due to CTX-M-14-producing Escherichia coli at ertapenem treatment in a patient with a coexisting urinary tract infection caused by the same pathogen. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2010, Volume: 14 Suppl 3 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Osteomyelitis; Spinal Diseases; Treatment Failure; Urinary Tract Infections	2010
Novel genetic environment of the plasmid-mediated KPC-3 gene detected in Escherichia coli and Citrobacter freundii isolates from China. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2011, Volume: 30, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; Citrobacter freundii; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Isoelectric Focusing; Meropenem; Microbial Sensitivity Tests; Middle Aged; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA; Thienamycins	2011
Bacteriology of infection in severe acute pancreatitis. JOP : Journal of the pancreas, 2011, Jan-05, Volume: 12, Issue:1 Topics: Acute Disease; Adult; Anti-Bacterial Agents; Cephalosporins; Comorbidity; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Longitudinal Studies; Male; Middle Aged; Outcome Assessment, Health Care; Pancreatitis; Prevalence; Prospective Studies; Severity of Illness Index; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome	2011
Antimicrobial resistance in more than 100,000 Escherichia coli isolates according to culture site and patient age, gender, and location. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fosfomycin; Humans; Imipenem; Infant; Male; Middle Aged; Nitrofurantoin; Retrospective Studies; Tobramycin; Young Adult	2011
[Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems]. Mikrobiyoloji bulteni, 2011, Volume: 45, Issue:1 Topics: Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Thienamycins	2011
Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae. Diagnostic microbiology and infectious disease, 2011, Volume: 70, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Thienamycins; Treatment Outcome	2011
Susceptibility of European Escherichia coli clinical isolates from intra-abdominal infections, extended-spectrum β-lactamase occurrence, resistance distribution, and molecular characterization of ertapenem-resistant isolates (SMART 2008-2009). Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:3 Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Europe; Female; Humans; Imipenem; Intraabdominal Infections; Male; Microbial Sensitivity Tests	2012
Transmission of imipenem resistance determinants during the course of an outbreak of NDM-1 Escherichia coli in a sick newborn care unit. The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:12 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Disease Outbreaks; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Transfer, Horizontal; Humans; Imipenem; Infant, Newborn; Male; Molecular Sequence Data; Sepsis; Sequence Analysis, DNA	2011
Cefoxitin as an alternative to carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15-type extended-spectrum β-lactamase. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:3 Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamases; beta-Lactams; Carbapenems; Cefoxitin; Ceftriaxone; Conjugation, Genetic; Disease Models, Animal; Drug Administration Schedule; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Kidney; Mice; Microbial Sensitivity Tests; Mutation Rate; Plasmids; Urinary Bladder; Urinary Tract Infections	2012
Carbapenem therapy for bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli or Klebsiella pneumoniae: implications of ertapenem susceptibility. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:6 Topics: Adult; Bacteremia; beta-Lactams; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Retrospective Studies; Thienamycins; Young Adult	2012
A 9-Year retrospective review of antibiotic cycling in a surgical intensive care unit. The Journal of surgical research, 2012, Volume: 176, Issue:2 Topics: Anti-Bacterial Agents; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Critical Care; Cross Infection; Drug Combinations; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Surgical Wound Infection	2012
Occurrence and phenotypic detection of class A carbapenemases among Escherichia coli and Klebsiella pneumoniae blood isolates at a tertiary care center. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2013, Volume: 46, Issue:2 Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Prevalence; Sepsis; Tertiary Care Centers; Thienamycins	2013
Determination of integron frequency by a polymerase chain reaction-restriction fragment length polymorphism method in multidrug-resistant Escherichia coli, which causes urinary tract infections. Microbial drug resistance (Larchmont, N.Y.), 2012, Volume: 18, Issue:6 Topics: Adult; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Female; Humans; Imipenem; Integrons; Male; Microbial Sensitivity Tests; Norfloxacin; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Urinary Tract Infections; Uropathogenic Escherichia coli	2012
Efficacies of calcium-EDTA in combination with imipenem in a murine model of sepsis caused by Escherichia coli with NDM-1 β-lactamase. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2013, Volume: 19, Issue:5 Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactam Resistance; beta-Lactamases; Colony Count, Microbial; Disease Models, Animal; Edetic Acid; Escherichia coli; Escherichia coli Infections; Imipenem; Mice; Microbial Sensitivity Tests; Sepsis	2013
Activity of combinations of ceftazidime, imipenem and pefloxacin against Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa. International journal of antimicrobial agents, 2003, Volume: 22, Issue:6 Topics: Animals; Ceftazidime; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Imipenem; In Vitro Techniques; Mice; Microbial Sensitivity Tests; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus	2003
Effect of moxifloxacin versus imipenem/cilastatin treatment on the mortality of mice infected intravenously with different strains of Bacteroides fragilis and Escherichia coli. The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:2 Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Bacteroides fragilis; Bacteroides Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; DNA, Bacterial; Drug Combinations; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Imipenem; Kidney; Liver; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Reverse Transcriptase Polymerase Chain Reaction	2004
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock. Annals of surgery, 2004, Volume: 239, Issue:2 Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Drug Synergism; Drug Therapy, Combination; Endotoxins; Escherichia coli; Escherichia coli Infections; Imipenem; Injections, Intraperitoneal; Insect Proteins; Lipopolysaccharides; Male; Piperacillin; Rats; Rats, Wistar; Shock, Septic	2004
In vivo acquisition of high-level resistance to imipenem in Escherichia coli. Journal of clinical microbiology, 2004, Volume: 42, Issue:8 Topics: Anti-Bacterial Agents; Base Sequence; Child; DNA Primers; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Microbial Sensitivity Tests	2004
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock. Peptides, 2005, Volume: 26, Issue:2 Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cecum; Drug Therapy, Combination; Endotoxins; Escherichia coli; Escherichia coli Infections; Imipenem; Injections, Intraperitoneal; Limulus Test; Lipopolysaccharides; Male; Piperacillin; Polymyxin B; Rats; Rats, Wistar; Shock, Septic; Time Factors; Tumor Necrosis Factor-alpha	2005
[Germs that produce the extended spectrum betalactamases]. La Tunisie medicale, 2004, Volume: 82, Issue:11 Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Emergencies; Escherichia coli; Escherichia coli Infections; Female; Hospitals, University; Humans; Imipenem; Leukemia; Lymphoma, Non-Hodgkin; Male; Morocco; Neutropenia; Retrospective Studies; Shock, Septic; Time Factors	2004
Escherichia coli: development of carbapenem resistance during therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, May-15, Volume: 40, Issue:10 Topics: Aged; Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins; Urinary Tract Infections	2005
In vivo transfer of plasmid-encoded ACC-1 AmpC from Klebsiella pneumoniae to Escherichia coli in an infant and selection of impermeability to imipenem in K. pneumoniae. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:8 Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Conjugation, Genetic; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Plasmids; Selection, Genetic	2005
LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:5 Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cathelicidins; Cecum; Disease Models, Animal; Endotoxins; Escherichia coli; Escherichia coli Infections; Gram-Negative Bacteria; Imipenem; Injections, Intraperitoneal; Male; Nitrites; Piperacillin; Polymyxin B; Random Allocation; Rats; Rats, Wistar; Serotyping; Shock, Septic; Tumor Necrosis Factor-alpha	2006
Isolation and characteristics of sorbitol-fermenting Escherichia coli O157 strains from cattle. Microbes and infection, 2006, Volume: 8, Issue:8 Topics: Adhesins, Bacterial; Animals; Anti-Bacterial Agents; Bacterial Toxins; Carbohydrate Epimerases; Cattle; Cattle Diseases; Cluster Analysis; DNA Fingerprinting; DNA, Bacterial; Escherichia coli Infections; Escherichia coli O157; Escherichia coli Proteins; Fermentation; Hemolysin Proteins; Hemolysis; Imipenem; Immunomagnetic Separation; Polymerase Chain Reaction; Random Amplified Polymorphic DNA Technique; Serine Endopeptidases; Shiga Toxin 1; Shiga Toxin 2; Sorbitol; Transaminases; Virulence Factors	2006
[Escherichia coli endocarditis: a report of two cases]. Enfermedades infecciosas y microbiologia clinica, 2007, Volume: 25, Issue:2 Topics: Aged; Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Combined Modality Therapy; Endocarditis, Bacterial; Escherichia coli Infections; Female; Gastroenteritis; Gentamicins; Heart Valve Prosthesis Implantation; Humans; Imipenem; Middle Aged; Urinary Tract Infections	2007
Ertapenem resistance of Escherichia coli. Emerging infectious diseases, 2007, Volume: 13, Issue:2 Topics: Anti-Bacterial Agents; Antifungal Agents; beta-Lactams; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Fluconazole; Gentamicins; Humans; Imipenem; Immunocompromised Host; Middle Aged; Vancomycin	2007
Ertapenem susceptibility of extended spectrum beta-lactamase-producing organisms. Annals of clinical microbiology and antimicrobials, 2007, Jun-06, Volume: 6 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Military Personnel	2007
Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli. The Journal of infection, 2007, Volume: 55, Issue:3 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Bile Duct Diseases; Community-Acquired Infections; Cross Infection; Drug Resistance; England; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Length of Stay; Male; Middle Aged; Odds Ratio; Prospective Studies; Urinary Tract Infections	2007
Pharmacokinetics and bacteriological efficacy of N-formimidoyl thienamycin in experimental Escherichia coli meningitis. Antimicrobial agents and chemotherapy, 1982, Volume: 21, Issue:3 Topics: Animals; Anti-Bacterial Agents; Escherichia coli Infections; Imipenem; Infusions, Parenteral; Injections, Intravenous; Kinetics; Lactams; Male; Meningitis; Rabbits	1982
Therapeutic efficacy of a polymyxin B-dextran 70 conjugate in experimental model of endotoxemia. Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:7 Topics: Animals; Bacteremia; Dextrans; Disease Models, Animal; Drug Carriers; Endotoxins; Escherichia coli Infections; Female; Galactosamine; Imipenem; Lipopolysaccharides; Mice; Polymyxin B; Toxemia	1995
Perforated acute appendicitis in a patient with AIDS/HIV infection: report of a case. Surgery today, 1995, Volume: 25, Issue:1 Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Appendectomy; Appendicitis; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Escherichia coli Infections; Fever of Unknown Origin; Granulocyte Colony-Stimulating Factor; Humans; Imipenem; Immunization, Passive; Intestinal Perforation; Male; Postoperative Complications; Rupture, Spontaneous	1995
Differences in therapeutic efficacy among cell wall-active antibiotics in a mouse model of gram-negative sepsis. The Journal of infectious diseases, 1995, Volume: 172, Issue:6 Topics: Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Ceftazidime; Cell Wall; Escherichia coli Infections; Female; Galactosamine; Gram-Negative Bacterial Infections; Imipenem; Lipopolysaccharides; Mice; Mice, Inbred C3H; Sepsis	1995
Psoas abscess following ileo-anal pouch surgery. The Australian and New Zealand journal of surgery, 1995, Volume: 65, Issue:5 Topics: Adult; Colitis, Ulcerative; Drug Therapy, Combination; Enterobacteriaceae Infections; Escherichia coli Infections; Gentamicins; Humans; Imipenem; Male; Proctocolectomy, Restorative; Psoas Abscess	1995
Differential antibiotic-induced release of endotoxin from gram-negative bacteria. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1994, Volume: 13 Suppl 1 Topics: Animals; Ceftazidime; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Female; Galactosamine; Imipenem; Lipid A; Lipopolysaccharides; Mice; Microbial Sensitivity Tests	1994
Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis. The Journal of infectious diseases, 1994, Volume: 169, Issue:4 Topics: Abscess; Amoxicillin; Animals; Anti-Bacterial Agents; Bacteremia; Bacteroides fragilis; Bacteroides Infections; Body Weight; Disease Models, Animal; Drug Synergism; Enterococcus faecalis; Escherichia coli; Escherichia coli Infections; Gentamicins; Gram-Positive Bacterial Infections; Imipenem; Male; Microbial Sensitivity Tests; Ornidazole; Pefloxacin; Peritoneum; Peritonitis; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms	1994
The treatment of irradiated mice with polymicrobial infection caused by Bacteroides fragilis and Escherichia coli. The Journal of antimicrobial chemotherapy, 1994, Volume: 33, Issue:2 Topics: Abscess; Animals; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Feces; Female; Imipenem; Immunocompromised Host; Liver; Metronidazole; Mice; Microbial Sensitivity Tests; Ofloxacin; Whole-Body Irradiation	1994
Impact of different classes antimicrobial agents on plasma endotoxin activity. Archives of surgery (Chicago, Ill. : 1960), 1996, Volume: 131, Issue:2 Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Blood Pressure; Cefotaxime; Cephalosporins; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Endotoxins; Escherichia coli; Escherichia coli Infections; Gentamicins; Imipenem; Male; Peritoneal Diseases; Peritoneum; Rats; Rats, Wistar; Thienamycins	1996
[In vitro antibacterial activity of a new parenteral penem, sulopenem]. The Japanese journal of antibiotics, 1996, Volume: 49, Issue:4 Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactams; Carrier Proteins; Cells, Cultured; Escherichia coli Infections; Hexosyltransferases; Imipenem; Lactams; Macrophages; Male; Mice; Mice, Inbred ICR; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases	1996
[In vitro and in vivo activities of sulopenem compared with those of imipenem and cephalosporins]. The Japanese journal of antibiotics, 1996, Volume: 49, Issue:4 Topics: Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; beta-Lactam Resistance; Cefotaxime; Ceftizoxime; Cephalosporins; Escherichia coli Infections; Gram-Negative Bacteria; Gram-Positive Bacteria; Guinea Pigs; Imipenem; Klebsiella Infections; Lactams; Lung Diseases; Mice; Mice, Inbred ICR; Thienamycins	1996
Bacteremia versus endotoxemia in experimental mouse leukopenia--role of antibiotic chemotherapy. The Journal of infectious diseases, 1996, Volume: 174, Issue:6 Topics: Animals; Antibodies, Monoclonal; Bacteremia; Ceftazidime; Cephalosporins; Cyclophosphamide; Endotoxemia; Escherichia coli; Escherichia coli Infections; Female; Galactosamine; Imipenem; Immunity, Innate; Interferon-gamma; Leukopenia; Mice; O Antigens; Thienamycins	1996
Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:3 Topics: Amino Acid Sequence; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; Blotting, Southern; Carbapenems; Disease Outbreaks; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Infant; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids	1997
[A case of septic shock following incarceration of the penis]. Hinyokika kiyo. Acta urologica Japonica, 1998, Volume: 44, Issue:3 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Escherichia coli Infections; gamma-Globulins; Humans; Imipenem; Male; Methylprednisolone; Minocycline; Penis; Shock, Septic	1998
[Clinical of 50 cases of aged patients with pneumonia caused by gram-negative bacteria]. Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University, 1998, Volume: 23, Issue:2 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Therapy, Combination; Escherichia coli Infections; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Kanamycin; Male; Middle Aged; Penicillins; Pneumonia, Bacterial; Thienamycins	1998
[A case of effective endotoxin adsorption therapy for septic shock due to acute pyelonephritis]. Hinyokika kiyo. Acta urologica Japonica, 2000, Volume: 46, Issue:11 Topics: Acute Disease; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Endotoxins; Escherichia coli; Escherichia coli Infections; Hemofiltration; Humans; Imipenem; Male; Middle Aged; Pyelonephritis; Shock, Septic; Sorption Detoxification; Treatment Outcome; Ureteral Calculi	2000
Therapeutic efficacy of the polymyxin-like peptide ranalexin in an experimental model of endotoxemia. The Journal of surgical research, 2001, Volume: 100, Issue:2 Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Disease Models, Animal; Endotoxemia; Escherichia coli Infections; Imipenem; Male; Peptides, Cyclic; Polymyxin B; Polymyxins; Rats; Survival Rate; Thienamycins; Tumor Necrosis Factor-alpha	2001
Broad resistance due to plasmid-mediated AmpC beta-lactamases in clinical isolates of Escherichia coli. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Jul-15, Volume: 35, Issue:2 Topics: Adult; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Blotting, Western; Cephalosporin Resistance; Conjugation, Genetic; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Gene Amplification; Humans; Imipenem; Male; Microbial Sensitivity Tests; Nucleic Acid Hybridization; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA	2002
Inhibition of nitric oxide synthesis improves survival in a murine peritonitis model of sepsis that is not cured by antibiotics alone. The Journal of antimicrobial chemotherapy, 1992, Volume: 30, Issue:6 Topics: Amino Acid Oxidoreductases; Animals; Arginine; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Escherichia coli Infections; Imipenem; Male; Mice; Nitric Oxide Synthase; omega-N-Methylarginine; Peritonitis	1992
Bilateral emphysematous pyelonephritis resolving to medical therapy. Journal of internal medicine, 1992, Volume: 232, Issue:1 Topics: Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Drug Combinations; Emphysema; Escherichia coli Infections; Female; Humans; Imipenem; Middle Aged; Pyelonephritis; Tomography, X-Ray Computed	1992
Relation between the therapeutic efficacy of imipenem in an experimental infection in granulocytopenic mice and its effect on murine intestinal microbial ecology. The Journal of antimicrobial chemotherapy, 1990, Volume: 26, Issue:3 Topics: Animals; Cilastatin; Cilastatin, Imipenem Drug Combination; Colony Count, Microbial; Drug Combinations; Escherichia coli Infections; Imipenem; Injections, Subcutaneous; Intestines; Male; Mice; Muscular Diseases; Specific Pathogen-Free Organisms; Thigh	1990
Comparative chemotherapeutic activity of cefpirome and imipenem in experimental infections. The Journal of antibiotics, 1990, Volume: 43, Issue:1 Topics: Abscess; Animals; Bacterial Infections; Cefotaxime; Cefpirome; Cephalosporins; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Granuloma; Imipenem; Male; Mice; Mice, Hairless; Mice, Inbred C3H; Pneumonia; Rats; Rats, Inbred Strains; Sepsis; Staphylococcal Skin Infections; Staphylococcus aureus; Streptococcal Infections	1990
Evaluation of FCE 22101 in experimental meningitis caused by Escherichia coli and Streptococcus pneumoniae. The Journal of antimicrobial chemotherapy, 1989, Volume: 23 Suppl C Topics: Animals; Anti-Bacterial Agents; Blood Bactericidal Activity; Carbapenems; Ceftriaxone; Escherichia coli Infections; Imipenem; Meningitis; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Penicillins; Rabbits	1989
[Clinical and pharmacokinetic study of imipenem/cilastatin in children and newborn infants]. Pathologie-biologie, 1989, Volume: 37, Issue:5 Topics: Adolescent; Bacterial Infections; Child; Child, Preschool; Cilastatin; Drug Therapy, Combination; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Imipenem; Infant, Newborn; Male; Pseudomonas Infections; Serratia	1989
In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice. The Journal of infectious diseases, 1989, Volume: 160, Issue:4 Topics: Abscess; Ampicillin; Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Cefamandole; Cefotetan; Cefoxitin; Ceftizoxime; Cilastatin; Cilastatin, Imipenem Drug Combination; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Imipenem; Male; Mice; Skin Diseases; Sulbactam	1989
Therapeutic effects of imipenem-cilastatin on experimental intrauterine infections in rats. Antimicrobial agents and chemotherapy, 1987, Volume: 31, Issue:4 Topics: Ampicillin; Animals; Cefazolin; Cilastatin; Cyclopropanes; Drug Combinations; Drug Evaluation, Preclinical; Endometritis; Enterococcus faecalis; Escherichia coli Infections; Female; Imipenem; Microbial Sensitivity Tests; Neutropenia; Rats; Rats, Inbred Strains; Streptococcal Infections; Thienamycins	1987
[A clinical study on imipenem/cilastatin sodium in the field of pediatrics]. The Japanese journal of antibiotics, 1986, Volume: 39, Issue:7 Topics: Bacterial Infections; Child, Preschool; Cilastatin; Cyclopropanes; Drug Combinations; Escherichia coli Infections; Female; Gastroenteritis; Haemophilus Infections; Humans; Imipenem; Infant; Male; Neisseria; Respiratory Tract Infections; Streptococcal Infections; Thienamycins; Urinary Tract Infections	1986
Imipenem/cilastatin for the treatment of infections in hospitalized children. American journal of diseases of children (1960), 1985, Volume: 139, Issue:11 Topics: Arthritis, Infectious; Bacterial Infections; Cellulitis; Child; Child, Preschool; Cilastatin; Cyclopropanes; Dipeptidases; Drug Combinations; Escherichia coli Infections; Female; Haemophilus Infections; Hospitalization; Humans; Imipenem; Infant; Kidney Diseases; Lymphadenitis; Male; Prospective Studies; Pseudomonas Infections; Staphylococcal Infections; Streptococcal Infections; Thienamycins; Wound Infection	1985
Comparison of cefotaxime, imipenem-cilastatin, ampicillin-gentamicin, and ampicillin-chloramphenicol in the treatment of experimental Escherichia coli bacteremia and meningitis. Antimicrobial agents and chemotherapy, 1985, Volume: 28, Issue:3 Topics: Ampicillin; Animals; Animals, Newborn; Cefotaxime; Chloramphenicol; Cilastatin; Cyclopropanes; Dose-Response Relationship, Drug; Drug Therapy, Combination; Escherichia coli Infections; Gentamicins; Imipenem; Meningitis; Rats; Sepsis; Thienamycins	1985